YourLawyer.com® 1-800-LAW-INFO (1-800-529-4636)

Parker Waichman Alonso LLP Headlines by Topic

Vytorin

Vytorin Prescriptions Still Lag

Mar 20, 2008 | Parker Waichman Alonso LLP
Vytorin prescriptions have yet to recover from the dive they took in January, following the release of a study that showed the expensive...

More Heat for Vytorin and Avandia

Mar 5, 2008 | Parker Waichman Alonso LLP
Avandia and Vytorin are the subject of yet another government investigation.  The Government Accountability Office (GAO) will look into whether...

Vytorin Prescriptions Down Again After Brief Reprieve

Feb 20, 2008 | Parker Waichman Alonso LLP
Vytorin prescriptions have fallen again, dashing hopes at Merck and Schering-Plough that the fallout from a disappointing Vytorin study was starting...

Vytorin Revelations Lead to Cholesterol Debate

Feb 5, 2008 | Parker Waichman Alonso LLP
The Vytorin debacle has sparked some in the medical community to reassess the importance of controlling LDL – so-called bad –cholesterol...

Vytorin Lawsuits Keep Coming

Feb 4, 2008 | Parker Waichman Alonso LLP
Vytorin makers Merck and Schering-Plough are facing yet another lawsuit, this time from the plaintiffs in Nevada.  The Nevada Vytorin consumer...

Vytorin in Connecticut Crosshairs

Jan 29, 2008 | Parker Waichman Alonso LLP
Connecticut can now be added to the list of states investigating Vytorin.  According to The Wall Street Journal, Connecticut Attorney General...

Vytorin Mess Attracts Attention of New York Attorney General

Jan 28, 2008 | Parker Waichman Alonso LLP
The Vytorin mess seems to be getting worse for Merck and Schering-Plough.  Already facing a firestorm over its handling of the so-called ENHANCE...

Vytorin Latest Drug Scandal to Raise Questions about FDA Oversight

Jan 25, 2008 | Parker Waichman Alonso LLP
The Vytorin controversy has once again raised serious questions about the way the Food & Drug Administration (FDA) approves new drugs.  At...

FDA Issues Vytorin Early Communication

Jan 25, 2008 | Parker Waichman Alonso LLP
The Food & Drug Administration (FDA) weighed in on the Vytorin controversy today by issuing an Early Communication about its ongoing reviews of...

Vytorin Support Statement Raises Questions Over American Heart Association Funding

Jan 24, 2008 | Parker Waichman Alonso LLP
Vytorin appears to have an important ally.   One day after news broke that a study had shown Vytorin to be ineffective in preventing...

Page 5/6 [first] [prev] 1 2 3 4 5 6 [next] [last]

Vytorin
* Denotes required field.

Title

* First Name

* Last Name

* Email Address

* Phone Number

Cell Phone Number

Office Phone Number

Street Address

Apartment/Suite

City

State

Zip Code

Please provide the best method and times to contact you:

Date of birth of person injured
(mm-dd-yyyy):

Date you started taking the drug (mm-yyyy):

Date you stopped taking the drug (mm-yyyy):

What condition was this medication prescribed to treat?


What Type of Incident Did You have (Heart Attack, Stroke, etc)

Incident Date

How Long Were You On Vytorin Before The Incident Occured

If other, please explain:

Did insurance cover your medication?

What was your total out of pocket expense?

Other Info:

No Yes, I agree to the Parker Waichman Alonso LLP disclaimers.Click here to review all.

Yes, I would like to receive the Parker Waichman Alonso LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Home | Defective Drugs | Medical Devices | Toxic Substances | Accidents | Product Liability | Malpractice | Diseases
Nursing Home Negligence | Food Poisoning | Other Topics | Social Security Disability | Contact
Statement of Clients' Rights | Site Map | Drug Injury Search | Vioxx | Mesothelioma | Permax | Dostinex | Composix Kugel Mesh X Large Patch
Ortho Evra | Fosamax | Personal Injury Lawyer | Fusarium Keratitis | Stevens Johnson Syndrome | Florida Personal Injury Law Firm

© 2002-2009 YourLawyer.com®. All Rights Reserved.

Please note that you are not considered a client until you have signed a retainer agreement and your case has been accepted by us.
Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Attorney Advertising

Parker Waichman Personal Injury News